In mice with chronic kidney disease, a two- to three-fold increase in myostatin expression was detected in muscle (Zhang et al., 2011); after 7 days of treatment with the anti-myostatin peptibody, muscle weights in mice with chronic kidney disease was significantly greater than those in vehicle-treated chronic kidney disease mice. This evidence concerns the gene MSTN and chronic kidney disease.